Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Health Canada Approves First Vaccine to Help Prevent Cervical Cancer

July 19, 2006

On Tuesday, Health Canada gave its approval to the first vaccine to prevent the STD human papillomavirus (HPV). The approval of Gardasil, to be sold in Canada by Merck Frosst Canada, follows similar action last month by the U.S. Food and Drug Administration. Like FDA, Health Canada approved Gardasil determine Gardasil's effectiveness in women beyond that age and in men. Gardasil protects against the four strains of HPV that cause about 70 percent of cervical cancer cases, plus genital warts and cancers of the vulva and vagina. The Canadian Cancer Society hailed Health Canada's approval of Gardasil, saying the vaccine could prevent hundreds of cervical cancer cases in the country each year.

Back to other news for July 19, 2006

Adapted from:
Canadian Press
07.18.06; Sheryl Ubelacker


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News

Tools
 

Advertisement